COVID-19 and rare diseases: reflections and recommendations by the International Rare Diseases Research Consortium

Abstract

Aim: The ambitious goals set by the International Rare Diseases Research Consortium (IRDiRC) by 2027 to fulfill the vision of providing diagnosis and treatments to rare diseases (RDs) patients within one year of coming to medical attention have been challenged by the COVID-19 pandemic. This article aims to identify the needs and challenges of the RD community during the COVID-19 pandemic and to understand whether the pandemic would hinder achievement of the IRDiRC goals.

Methods: A survey was developed in 2020 to answer key issues related to the potential impact of the pandemic on RD research and distributed to all 96 IRDiRC Constituent Committee members and Scientific Committee experts.

Results: The overall participation rate was 46%, with the highest response rates from the Patient Advocates, Funders, and Therapies Committees. Most respondents reported impacts on various aspects of RD research including decreased access to healthcare, clinical trials, and diagnostics for patients, as well as disrupted operations for patient and funding organizations and restrictions in access to workplaces for researchers. Despite these challenges, there was overall optimism that the IRDiRC goals could still be met by 2027, although there would be an inevitable slowdown in RD research activities.

Conclusions: Maintaining funding for RD research and implementing new workflows to ensure that patients have continued access to diagnostics, therapies, and clinical trials will be key to ensuring that IRDiRC meets it goals by 2027.

Keywords

IRDiRC / rare diseases / COVID-19 / survey / recommendations

References

[1] Kabanova A,Pelzer BW,Maiques-Diaz A.Effect of the COVID-19 pandemic on laboratory and clinical research: a testimony and a call to action from researchers.Hemasphere2020;4:e499 PMCID:PMC7710232

[2] Singh JA,Bukusi EA.The impact of the COVID-19 pandemic response on other health research.Bull World Health Organ2020;98:625-31 PMCID:PMC7463185

[3] Sohrabi C,Franchi T.Impact of the coronavirus (COVID-19) pandemic on scientific research and implications for clinical academic training - a review.Int J Surg2021;86:57-63 PMCID:PMC7833269

[4] Weiner DL,Shah SI.Pediatric Policy CouncilCOVID-19 impact on research, lessons learned from COVID-19 research, implications for pediatric research.Pediatr Res2020;88:148-50

[5] National Institutes of Health. NIH workforce COVID-19 impact survey. Available from: https://diversity.nih.gov/sites/coswd/files/images/docs/25690_Trans-NIH_COVID-19_Executive_Summary_508_v2.pdf [Last accessed on 22 Dec 2021]

[6] Myers KR,Yin Y.Unequal effects of the COVID-19 pandemic on scientists.Nat Hum Behav2020;4:880-3

[7] National Institutes of Health. 2020 NIH extramural surveys: the impact of COVID-19 on the Research Community. Available from: https://diversity.nih.gov/sites/coswd/files/images/images/NIH_COSWD_COVID19_Impact_Infographic_vF_Updated_3-19.pdf [Last accessed on 22 Dec 2021]

[8] Nguengang Wakap S,Olry A.Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database.Eur J Hum Genet2020;28:165-73 PMCID:PMC6974615

[9] Haendel M,Unni D.How many rare diseases are there?.Nat Rev Drug Discov2020;19:77-8 PMCID:PMC7771654

[10] United Nations. Universal health coverage: moving together to build a healthier world. Available from: https://www.un.org/pga/73/wp-content/uploads/sites/53/2019/07/FINAL-draft-UHC-Political-Declaration.pdf [Last accessed on 22 Dec 2021]

[11] IRDiRC. Member Organizations Available from: https://irdirc.org/about-us/people-organisation/members-organizations/ [Last accessed on 22 Dec 2021]

[12] Dawkins HJS,Lasko P.International Rare Diseases Research Consortium (IRDiRC)Progress in Rare Diseases Research 2010-2016: an IRDiRC perspective.Clin Transl Sci2018;11:11-20 PMCID:PMC5759730

[13] Cutillo CM,Groft SC.A global approach to rare diseases research and orphan products development: the International Rare Diseases Research Consortium (IRDiRC). In: Posada de la Paz M, Taruscio D, Groft SC, editors. Rare diseases epidemiology: update and overview. Cham: Springer International Publishing; 2017. p. 349-69.

[14] Julkowska D,Cutillo CM.The importance of international collaboration for rare diseases research: a European perspective.Gene Ther2017;24:562-71 PMCID:PMC5628265

[15] Austin CP,Lau LPL.International Rare Diseases Research Consortium (IRDiRC)Future of rare diseases research 2017-2027: an IRDiRC perspective.Clin Transl Sci2018;11:21-7 PMCID:PMC5759721

[16] IRDiRC. Task Forces & Working Groups. Available from: https://irdirc.org/activities/task-forces/ [Last accessed on 22 Dec 2021]

[17] IRDiRC. Minutes of the 20th Consortium Assembly Meeting. Available from: https://irdirc.org/wp-content/uploads/2020/11/Report_20th-CA-meeting_October-2020.pdf [Last accessed on 22 Dec 2021]

[18] European Union. Coronavirus: Commission steps up research funding with €120 million for 11 new projects to tackle the virus and its variants. Available from: https://ec.europa.eu/commission/presscorner/detail/en/IP_21_3803 [Last accessed on 22 Dec 2021]

[19] National Institutes of Health. COVID-19 Funded Research Projects. Available from: https://covid19.nih.gov/funding#:~:text=NIH%20has%20received%20almost%20%244.9,coming%20from%20the%20U.S.%20Congress%20 [Last accessed on 22 Dec 2021]